Biomerica BMRA
NASDAQ BMRA
$1.59 +0.07 (+4.82%)
At close: Aug 20, 2026 · 1:51 PM UTC

Biomerica (BMRA) Other Non Operating Income (2010 - 2026)

Biomerica (BMRA) posted Other Non Operating Income of -$6000.0 for Q1 2026, up 97.21% sequentially from -$215000.0 in Q2 2025, and down 113.95% YoY from $43000.0 in Q1 2025.

Biomerica (BMRA) Other Non Operating Income (2010 - 2026) Analysis & Trends

Biomerica has reported Other Non Operating Income for 6 years, with the latest figure at -$6000.0 in Q1 2026.

  • Quarterly Other Non Operating Income fell 113.95% year-over-year to -$6000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$173014.0 (down 407.9% YoY) and the FY2025 annual result came in at -$75000.0, up 56.4% from the prior year.
  • Other Non Operating Income improved to -$6000.0 in Q1 2026 per BMRA's latest filing, from -$215000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $43000.0 in Q1 2025 and troughed at -$215000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn
10 Biomerica 4.79 Mn 3.45 Mn -44,000.00

Historic Data

Download Data
DateValue
Feb 28, 2026 -6,000.00
May 31, 2025 -215,000.00
Feb 28, 2025 43,000.00
May 31, 2013 4,986.00
Feb 28, 2013 7,079.00
Nov 30, 2012 1,127.00
Aug 31, 2012 808.00
May 31, 2012 27,265.00
Feb 29, 2012 72,526.00
Nov 30, 2011 1,006.00
Aug 31, 2011 891.00
May 31, 2011 113,523.00
Feb 28, 2011 388.00
Nov 30, 2010 177,752.00